Cellectis S.A. (CLLS)

Cellectis Income Statement

Financials in millions EUR. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	12.13	9.19	25.73	38.6	59.56	22.99
Revenue Growth (YoY)	-52.39%	-64.26%	-33.35%	-35.20%	159.09%	7.27%
Cost of Revenue	0.4	0.74	1.77	1.84	1.95	11.39
Gross Profit	11.73	8.46	23.95	36.75	57.61	11.6
Selling, General & Admin	16.95	16.81	17.49	22.88	22.51	43.02
Research & Development	88.89	87.65	97.5	117.84	77.05	92.04
Other Operating Expenses	0.65	1.3	-1.38	-0.49	0.36	0.09
Operating Expenses	106.5	105.76	113.62	140.23	99.92	135.15
Operating Income	-94.77	-97.3	-89.67	-103.48	-42.31	-123.55
Interest Expense / Income	38.6	40.64	17.82	6.49	16.12	3.63
Other Expense / Income	-68.13	-37.26	-1.43	4.23	22.65	-25.09
Pretax Income	-65.23	-100.69	-106.05	-114.2	-81.07	-102.09
Income Tax	0.11	0.37	0.09	0	0	0
Net Income	-65.34	-101.06	-106.14	-114.2	-81.07	-102.09
Shares Outstanding (Basic)	72	57	46	45	42	42
Shares Outstanding (Diluted)	-	57	46	45	-	-
Shares Change	39.57%	25.17%	1.62%	5.49%	0.13%	0.06%
EPS (Basic)	-1.11	-1.77	-2.33	-2.55	-1.91	-2.41
EPS (Diluted)	-1.34	-1.77	-2.33	-2.55	-1.91	-2.41
Free Cash Flow	-20.81	-25.82	-89.88	-123.11	-124.34	-81.64
Free Cash Flow Per Share	-0.29	-0.45	-1.97	-2.75	-2.93	-1.92
Gross Margin	96.68%	91.98%	93.11%	95.22%	96.72%	50.45%
Operating Margin	-781.12%	-1058.44%	-348.55%	-268.11%	-71.03%	-537.42%
Profit Margin	-538.59%	-1099.30%	-412.59%	-295.87%	-136.11%	-444.07%
Free Cash Flow Margin	-171.55%	-280.85%	-349.37%	-318.95%	-208.75%	-355.12%
EBITDA	-8	-41.52	-69.8	-93.56	-57.12	-91.59
EBITDA Margin	-65.91%	-451.68%	-271.34%	-242.39%	-95.90%	-398.37%
Depreciation & Amortization	18.64	18.52	18.44	14.16	7.83	6.88
EBIT	-26.63	-60.05	-88.24	-107.71	-64.96	-98.46
EBIT Margin	-219.52%	-653.17%	-343.00%	-279.07%	-109.05%	-428.27%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).